PREBIOTICS IN INFANT FORMULAS
https://doi.org/10.15690/vsp.v14i1.1260
Abstract
Microbiota of the gastrointestinal tract is different in breastfed infants and in children receiving standard infant formulas. While breast milk is rich in prebiotic oligosaccharides and can also contain some probiotics, standard infant formulas contain neither one thing nor the other. The formulation of an infant formula includes various prebiotic ingredients: galacto- and fructooligosaccharides, polydextrose and their combinations. There is evidence that the addition of prebiotics to baby food makes the microbiota of the gastrointestinal tract of infants receiving infant formulas more similar to the microbiota of breastfed children. Prebiotics alter the metabolic activity of the intestinal microflora (lower stool pH and increase the amount of short-chain fatty acids), have a bifidogenic effect and provide a stool consistency and bowel movement frequency that are similar to these parameters in breastfed infants. There is limited evidence that such changes in microbiota of the gastrointestinal tract may have some influence on the development of an infant's immune system. Adverse events are extremely rare in the application of prebiotics.
About the Authors
Yvan Vandenplas
Paediatric Gastroenterology, UZ Brussels, Free University of Brussels, Belgium
Belgium
Belgium
I. N. Zakharova
Russian Medical Academy of Postgraduate Education, Moscow, Russian Federation
Russian Federation
Russian Federation
Yu. A. Dmitrieva
Russian Medical Academy of Postgraduate Education, Moscow, Russian Federation
Russian Federation
Russian Federation
References
1. Kunz C., Rudloff S., Baier W., Klein N., Strobel S. Oligo saccharides in human milk: structural, functional, and metabolic aspects. Ann. Rev. Nutr. 2000; 20: 699–722.
2. Harmsen H. J., Wildeboer-Veloo A. C., Raangs G. C., Wagendorp A. A., Klijn N., Bindels J. G., Welling G. W. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J. Pediatr. Gastroenterol. Nutr. 2000; 30: 61–7l.
3. Johnson C. L., Versalovic J. The human microbiome and its potential importance to pediatrics. Pediatrics. 2012; 129: 950–960.
4. Gibson G. R., Roberfroid M. B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 1995; 125: 1401–1412.
5. Zakharova I. N., Dmitrieva Yu. A. Pre- and probiotics in infant formulas. Pediatrics. Suppl. to Consilium medicum. 2011; 3: 20–24.
6. Roberfroid M., Gibson G. R., Hoyles L., McCartney A. L., Ras-tall R., Rowland I., Wolvers D., Watzl B., Szajewska H., Stahl B., Guarner F., Respondek F., Whelan K., Coxam V., Davicco M. J., Leotoing L., Wittrant Y., Delzenne N. M., Cani P. D., Neyrinck A. M., Meheust A. Prebiotic effects: metabolic and health benefits. Brit. J. Nutr. 2010; 104 (Suppl. 2): 1–63.
7. Yaron S., Shachar D., Abramas L., Riskin A., Bader D., Litmanovitz I., Bar-Yoseph F., Cohen T., Levi L., Lifshitz Y., Shamir R., Shaoul R. Effect of high -palmitate content in infant formula on the intestinal microbiota of term infants. J. Pediatr. Gastroenterol. Nutr. 2013; 56: 376–381.
8. Nakamura N., Gaskins H. R., Collier C. T., Nava G. M., Rai D., Petschow B., Russell W. M., Harris C., Mackie R. I., Wampler J. L., Walker D. C. Molecular ecological analysis of fecal bacterial populations from term infants fed formula supplemented with selected blends of prebiotics. Appl. Environ. Microbiol. 2009; 75: 1121–1128.
9. Watson D., O’Connell Motherway M., Schoterman M. H., van Neerven R. J., Nauta A., van Sinderen D. Selective carbohydrate utilization by lactobacilli and bifidobacteria. J. Appl. Microbiol. 2013; 114: 1132–1146.
10. Gonzalez R., Klaassens E. S., Malinen E., de Vos W. M., Vaughan E. E. Differential transcriptional response of Bifidobacterium longum to human milk, formula milk, and galactooligosaccharide. Appl. Environ. Microbiol. 2008; 74: 4686–4694.
11. Kapiki A., Costalos C., Oikonomidou C., Triantafyllidou A., Pertro hilou V. The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infants. Early Hum. Dev. 2007; 83: 335–339.
12. Costalos C., Kapiki A., Apostolou M., Papathoma E. The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants. Early Hum. Dev. 2008; 84: 45–49.
13. Knol J., Scholtens P., Kafka C., Steenbakkers J., Gro S., Helm K., Klarczyk M., Schopfer H., Bockler H. M., Wells J. Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants. J. Pediatr. Gastroenterol. Nutr. 2005; 40: 36–42.
14. Scholtens P. A., Alliet P., Raes M., Alles M. S., Kroes H., Boehm G., Knippels L. M., Knol J., Vandenplas Y. Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides. J. Nutr. 2008; 138: 1141–1147.
15. Sierra C., Bernal M. J., Blasco J., Martinez R., Dalmau J., Ortuno I., Espin B., Vasallo M. I., Gil D., Vidal M. L., Infante D., Leis R., Maldonado J., Moreno J. M., Roman E. Prebiotic effect during the first year of life in healthy infants fed formula containing GOS as the only prebiotic: a multicentre, randomised, double-blind and placebo-controlled trial. Eur. J. Nutr. 2015; 54 (1): 89–99.
16. Ben X. M., Li J., Feng Z. T., Shi S. Y., Lu Y. D., Chen R., Zhou X. Y. Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal Bifidobacteria and Lactobacilli. World J. Gastroenterol. 2008; 14: 6564–6568.
17. Ben X. M., Zhou X. Y., Zhao W. H., Yu W. L., Pan W., Zhang W. L., Wu S. M., Van Beusekom C. M., Schaafsma A. Supplementation of milk formula with galacto-oligosaccharides improves intestinal micro-flora and fermentation in term infants. Chin. Med. J. 2004; 117: 927–931.
18. Rinne M. M., Gueimonde M., Kalliomaki M., Hoppu U., Salminen S. J., Isolauri E. Similar bifidogenic effects of prebiotic-supple-men ted partially hydrolyzed infant formula and breastfeeding on infant gut microbiota. FEMS Immunol. Med. Microbiol. 2005; 43: 59–65.
19. Fedorak R. N., Madsen K. I. Probiotics and prebiotics in gastrointestinal disorders. Curr. Opin. Gastroenterol. 2004; 20: 146–155.
20. Scalabrin D. M., Mitmesser S. H., Welling G. W., Harris C. L., Marunycz J. D., Walker D. C., Bos N. A., Tolkko S., Salminen S., Van-der hoof J. A. New prebiotic blend of polydextrose and galactooligosaccharides has a bifidogenic effect in young infants. J. Pediatr. Gastroenterol. Nutr. 2012; 54: 343–352.
21. Walton G. E., van den Heuvel E. G., Kosters M. H., Rastall R. A., Tuohy K. M., Gibson G. R. A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age. Brit. J. Nutr. 2012; 107: 1466–1475.
22. Ladirat S. E., Schuren F. H., Schoterman M. H., Nauta A., Grup-pen H., Schols H. A. Impact of galacto-oligosaccharides on the gut microbiota composition and metabolic activity upon antibiotic treatment during in vitro fermentation. FEMS Microbiol. Ecol. 2014; 87: 41–51.
23. Ashley C., Johnston W. H., Harris C. L., Stolz S. I., Wam pler J. L., Berseth C. L. Growth and tolerance of infants fed formula supplemented with polydextrose (PDX) and/or galactooligo saccharides (GOS): double-blind, randomized, controlled trial. Nutr. J. 2012; 11: 38.
24. Topping D. L., Clifton P. M. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol. Rev. 2001; 81: 1031–1064.
25. Bakker-Zierikzee A. M., Alles M. S., Knol J., Kok F. J., Tolboom J. J., Bindels J. G. Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life. Brit. J. Nutr. 2005; 94: 783–790.
26. Zakharova I., Sugyan N., Ardatskaya M. Metabolic activity of intestinal microflora while antibacterial therapy. Abs. PO-G-0171 presented on 46th ESPGHNAN Annual Meeting. London. 2013.
27. Rodriguez-Colinas B., Kolida S., Baran M., Ballesteros A. O., Rastall R. A., Plou F. J. Analysis of fermentation selectivity of purified galacto-oligosaccharides by in vitro human faecal fermentation. Appl. Microbiol. Biotechnol. 2013; 97: 5743–5752.
28. Schmelzle H., Wirth S., Skopnik H., Radke M., Knol J., Bockler H. M., Bronstrup A., Wells J., Fusch C. Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high beta-palmitic acid level, and nondigestible oligosaccharides. J. Pediatr. Gastroenterol. Nutr. 2003; 36: 343–351.
29. Mugambi M. N., Musekiwa A., Lombard M., Young T., Blaauw R. Synbiotics, probiotics or prebiotics in infant formula for full term infants: a systematic review. Nutr. J. 2012; 11: 81.
30. Rao S., Srinivasjois R., Patole S. Prebiotic supplementation in full-term neonates: a systematic review of randomized controlled trials. Arch. Pediatr. Adolesc. Med. 2009; 163: 755–764.
31. Piemontese P., Gianni M. L., Braegger C. P., Chirico G., Gruber C., Riedler J., Arslanoglu S., van Stuijvenberg M., Boehm G., Jelinek J., Roggero P. MIPS 1 Working Group. Tolerance and safety evaluation in a large cohort of healthy infants fed an innovative prebiotic formula: a randomized controlled trial. PLoS One. 2011; 6: 28010.
32. dos Santos E. F., Tsuboi K. H., Araujo M. R., Andreollo N. A., Miyasaka C. K Dietary galactooligosaccharides increase calcium absorption in normal and gastrectomized rats. Rev. Col. Bras. Cir. 2011; 38: 186–191.
33. Alliet P., Scholtens P., Raes M., Hensen K., Jongen H., Rum-mens J. L., Boehm G., Vandenplas Y. Effect of prebiotic galactooligosaccharide, long-chain fructo-oligosaccharide infant formula on serum cholesterol and triacylglycerol levels. Nutrition. 2007; 23: 719–723.
34. Bruzzese E., Volpicelli M., Squeglia V., Bruzzese D., Salvini F., Bisceglia M., Lionetti P., Cinquetti M., Iacono G., Amarri S., Guarino A. A formula containing galacto- and fructo-oligosaccha ri des prevents intestinal and extra-intestinal infections: an observational study. Clin. Nutr. 2009; 28: 156–161.
35. Arslanoglu S., Moro G. E., Schmitt J., Tandoi L., Rizzardi S., Boehm G. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J. Nutr. 2008; 138: 1091–1095.
36. Arslanoglu S., Moro G. E., Boehm G. Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. J. Nutr. 2007; 137: 2420–2424.
37. van Stuijvenberg M., Eisses A. M., Gruber C., Mosca F., Arslanoglu S., Chirico G., Braegger C. P., Riedler J., Boehm G., Sauer P. J. Do prebiotics reduce the number of fever episodes in healthy children in their first year of life: a randomised controlled trial. Brit. J. Nutr. 2011; 106: 1740–1748.
38. Braegger C., Chmielewska A., Decsi T., Kolacek S., Mihatsch W., Moreno L., Piescik M., Puntis J., Shamir R., Szajewska H., Turck D., van Goudoever J. ESPGHAN Committee on Nutrition. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. J. Pediatr. Gastroenterol. Nutr. 2011; 52: 238–250.
39. Fukushima Y., Kawata Y., Hara H., Terada A., Mitsuoka T. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int. J. Food Microbiol. 1998; 42: 39–44.
40. Yasui H., Mike A., Ohwaki M. Immunogenicity of Bifidobacterium breve and change in antibody production in Peyer’s patches after oral administration. J. Dairy Sci. 1989; 72: 30–35.
41. Seifert S., Watzl B. Inulin and oligofructose: review of experimental data on immune modulation. J. Nutr. 2007; 137 (11; Suppl.): 2563–2567.
42. Raes M., Scholtens P. A., Alliet P., Hensen K., Jongen H., Boehm G., Vandenplas Y., Rummens J. L. Exploration of basal immune parameters in healthy infants receiving an infant milk formula supplemented with prebiotics. Pediatr. Allergy Immunol. 2010; 21: 377–385.
43. Gopalakrishnan A., Clinthorne J. F., Rondini E. A., McCaskey S. J., Gurzell E. A., Langohr I. M., Gardner E. M., Fenton J. I. Supple men tation with galacto-oligosaccharides increases the percentage of NK cells and reduces colitis severity in Smad3-deficient mice. J. Nutr. 2012; 142: 1336–1342.
44. van Hoffen E., Ruiter B., Faber J., M’Rabet L., Knol E. F., Stahl B., Arslanoglu S., Moro G., Boehm G., Garssen J. A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy. Allergy. 2009; 64: 484–487.
45. Bakker-Zierikzee A. M., Tol E. A., Kroes H., Alles M. S., Kok F. J., Bindels J. G. Faecal SIgA secretion in infants fed on pre- or probiotic infant formula. Pediatr. Allergy Immunol. 2006; 17: 134–140.
46. Schouten B., Van Esch B. C., Kormelink T. G., Moro G. E., Arslanoglu S., Boehm G., Knippels L. M., Redegeld F. A., Willemsen L. E., Garssen J. Non-digestible oligosaccharides reduce immunoglobulin free light-chain concentrations in infants at risk for allergy. Pediatr. Allergy Immunol. 2011; 22: 537–542.
47. Tanabe S., Hochi S. Oral administration of a galactooligo sac-charide preparation inhibits development of atopic dermatitis-like skin lesions in NC/Nga mice. Int. J. Mol. Med. 2010; 25: 331–336.
48. Moro G., Arslanoglu S., Stahl B., Jelinek J., Wahn U., Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch. Dis. Child. 2006; 91: 814–819.
49. Williams H. C., Grindlay D. J. What’s new in atopic eczema? An analysis of systematic reviews published in 2007 and 2008. Part 2. Disease prevention and treatment. Clin. Exp. Dermatol. 2010; 35: 223–227.
50. Vos A. P., van Esch B., M’Rabet L., Folkerts G., Garssen J. Dietary supplementation with specific oligosaccharide mixtures decreases parameters of allergic asthma in mice. Int. Immunopharmacol. 2007; 6: 1277–1286.
51. Vos A. P., Haarman M., Buco A., Govers M., Knol J., Gars-sen J., Stahl B., Boehm G., M’Rabet L. A specific prebiotic oligosaccharide mixture stimulates delayed-type hypersensitivity in a murine influenza vaccination model. Int. Immunopharmacol. 2006; 6: 1277–1286.
52. Osborn D. A., Sinn J. K. Prebiotics in infants for prevention of allergy. Cochr. Database Syst. Rev. 2013; 3: CD006474.
53. Gourbeyre P., Desbuards N., Gremy G., Tranquet O., Champ M., Denery-Papini S., Bodinier M. Perinatal and postweaning exposure to galactooligosaccharides/inulin prebiotics induced biomarkers linked to tolerance mechanism in a mouse model of strong allergic sensitization. J. Agric. Food Chem. 2013; 61: 6311–6320.
54. Gruber C., van Stuijvenberg M., Mosca F., Moro G., Chirico G., Braegger C. P., Riedler J., Boehm G., Wahn U. MIPS 1 Working Group. Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J. Allergy Clin. Immunol. 2010; 126: 791–797.
Review
For citations:
Vandenplas Y., Zakharova I.N., Dmitrieva Yu.A. PREBIOTICS IN INFANT FORMULAS. Current Pediatrics. 2015;14(1):31-37. (In Russ.) https://doi.org/10.15690/vsp.v14i1.1260
Views:
2036
Email this article 
